Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 7/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10262535 | 1.00 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL756766 | 1.00 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL755199 | 1.00 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL758140 | 1.00 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL757961 | 1.00 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| Hydrochloric Acid SCHEMBL755698 | 0.99 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| Hydrochloric Acid SCHEMBL759413 | 0.99 | BACE1 (0.32) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL764691 | 0.88 | ADORA3 (0.40) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL760030 | 0.84 | BACE1 (0.34) | BACE1OPRM1OPRL1ADORA3ADORA1 | |
| SCHEMBL755862 | 0.84 | BACE1 (0.34) | BACE1OPRM1OPRL1ADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910364-A2 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck & Co., Inc. (US) | 2008-04-16 | — | — | EP | claimed |
| WO-2007011833-A2 | SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2007-01-25 | — | — | WO | claimed |